205 related articles for article (PubMed ID: 16212624)
1. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.
Lan YY; De Creus A; Colvin BL; Abe M; Brinkmann V; Coates PT; Thomson AW
Am J Transplant; 2005 Nov; 5(11):2649-59. PubMed ID: 16212624
[TBL] [Abstract][Full Text] [Related]
2. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3.
Maeda Y; Matsuyuki H; Shimano K; Kataoka H; Sugahara K; Chiba K
J Immunol; 2007 Mar; 178(6):3437-46. PubMed ID: 17339438
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
5. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
[TBL] [Abstract][Full Text] [Related]
6. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
[TBL] [Abstract][Full Text] [Related]
7. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
8. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.
Gollmann G; Neuwirt H; Tripp CH; Mueller H; Konwalinka G; Heufler C; Romani N; Tiefenthaler M
Int Immunol; 2008 Jul; 20(7):911-23. PubMed ID: 18495625
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
[TBL] [Abstract][Full Text] [Related]
11. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
Stone ML; Sharma AK; Zhao Y; Charles EJ; Huerter ME; Johnston WF; Kron IL; Lynch KR; Laubach VE
Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1245-52. PubMed ID: 25910934
[TBL] [Abstract][Full Text] [Related]
14. FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release.
Rolin J; Sand KL; Knudsen E; Maghazachi AA
Cancer Immunol Immunother; 2010 Apr; 59(4):575-86. PubMed ID: 19823820
[TBL] [Abstract][Full Text] [Related]
15. The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis.
Sui M; Zhou J; Xie R; Liu X; Mu S; Jia X; Ma J; Wu H
Mol Biol Rep; 2012 Jan; 39(1):389-97. PubMed ID: 21833515
[TBL] [Abstract][Full Text] [Related]
16. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.
Brinkmann V; Cyster JG; Hla T
Am J Transplant; 2004 Jul; 4(7):1019-25. PubMed ID: 15196057
[TBL] [Abstract][Full Text] [Related]
17. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Brinkmann V
Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
[TBL] [Abstract][Full Text] [Related]
18. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration.
Reines I; Kietzmann M; Mischke R; Tschernig T; Lüth A; Kleuser B; Bäumer W
J Invest Dermatol; 2009 Aug; 129(8):1954-62. PubMed ID: 19194476
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells.
Yopp AC; Ochando JC; Mao M; Ledgerwood L; Ding Y; Bromberg JS
J Immunol; 2005 Sep; 175(5):2913-24. PubMed ID: 16116177
[TBL] [Abstract][Full Text] [Related]
20. FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus.
Zhi L; Kim P; Thompson BD; Pitsillides C; Bankovich AJ; Yun SH; Lin CP; Cyster JG; Wu MX
J Immunol; 2011 Sep; 187(5):2244-51. PubMed ID: 21788441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]